Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In response the novel coronavirus emergency, the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has activated its Clinical Characterisation Protocol (CCP) for emerging infections in England and Scotland.

Similar stories

Landmark antibody study to test immune responses against COVID-19

Four UK centres will conduct the ‘Stratification of Clinically Vulnerable People for COVID-19 Risk using Antibody Testing (STRAVINSKY)’ study over the next two years, to identify the patient groups most vulnerable to COVID-19.